Chemomab Therapeutics Ltd.
CMMB
$1.23
$0.000.00%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -27.89% | -52.13% | -50.41% | -54.01% | -43.03% |
| Total Receivables | -9.00% | -37.24% | -37.04% | -59.19% | -48.55% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 91.84% | -- | -42.77% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | 0.00% | -1.30% | -- | -- |
| Total Current Assets | -23.24% | -51.43% | -49.93% | -54.10% | -43.08% |
|
|
|||||
| Total Current Assets | -23.24% | -51.43% | -49.93% | -54.10% | -43.08% |
| Net Property, Plant & Equipment | -22.45% | 23.90% | 17.00% | -29.95% | -18.29% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -31.13% | -26.93% | -23.74% | -29.31% | -27.29% |
| Total Assets | -23.42% | -49.59% | -48.56% | -53.37% | -42.56% |
|
|
|||||
| Total Accounts Payable | 29.07% | -52.58% | -69.43% | -41.38% | 49.09% |
| Total Accrued Expenses | -42.60% | -29.38% | -14.01% | 10.48% | 143.73% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 51.32% | 0.93% | -38.21% | -16.67% | -0.86% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -33.48% | -36.88% | -28.32% | -1.95% | 98.95% |
|
|
|||||
| Total Current Liabilities | -33.48% | -36.88% | -28.32% | -1.95% | 98.95% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -33.86% | 660.61% | 247.25% | -95.76% | -69.46% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -33.51% | -33.52% | -24.65% | -3.93% | 89.76% |
|
|
|||||
| Common Stock & APIC | 9.92% | 2.32% | 4.36% | 3.71% | 3.28% |
| Retained Earnings | -15.73% | -19.41% | -38.95% | -52.34% | -75.82% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -20.36% | -54.60% | -53.08% | -59.57% | -51.16% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -20.36% | -54.60% | -53.08% | -59.57% | -51.16% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -20.36% | -54.60% | -53.08% | -59.57% | -51.16% |
|
|
|||||